Envoy Medical (COCH) Competitors $1.35 +0.02 (+1.80%) Closing price 03:56 PM EasternExtended Trading$1.37 +0.02 (+1.18%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends COCH vs. ECOR, ZJYL, LNSR, PDEX, TELA, NSPR, EDAP, FONR, SRTS, and NTRBShould you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include electroCore (ECOR), Jin Medical International (ZJYL), LENSAR (LNSR), Pro-Dex (PDEX), TELA Bio (TELA), InspireMD (NSPR), Edap Tms (EDAP), FONAR (FONR), Sensus Healthcare (SRTS), and Nutriband (NTRB). These companies are all part of the "medical equipment" industry. Envoy Medical vs. electroCore Jin Medical International LENSAR Pro-Dex TELA Bio InspireMD Edap Tms FONAR Sensus Healthcare Nutriband Envoy Medical (NASDAQ:COCH) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation. Do insiders & institutionals believe in COCH or ECOR? 8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Comparatively, 19.7% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, COCH or ECOR? electroCore has higher revenue and earnings than Envoy Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$278K98.60-$29.91MN/AN/AelectroCore$23.33M4.26-$18.83M-$1.83-8.16 Which has more risk and volatility, COCH or ECOR? Envoy Medical has a beta of 2.36, indicating that its stock price is 136% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Does the MarketBeat Community favor COCH or ECOR? electroCore received 158 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 62.26% of users gave electroCore an outperform vote. CompanyUnderperformOutperformEnvoy MedicalOutperform Votes7100.00% Underperform VotesNo VoteselectroCoreOutperform Votes16562.26% Underperform Votes10037.74% Do analysts rate COCH or ECOR? Envoy Medical currently has a consensus price target of $8.00, suggesting a potential upside of 490.84%. electroCore has a consensus price target of $25.00, suggesting a potential upside of 67.45%. Given Envoy Medical's higher possible upside, equities research analysts clearly believe Envoy Medical is more favorable than electroCore.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00electroCore 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is COCH or ECOR more profitable? electroCore has a net margin of -54.40% compared to Envoy Medical's net margin of -7,607.55%. Envoy Medical's return on equity of 0.00% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets Envoy Medical-7,607.55% N/A -262.28% electroCore -54.40%-154.45%-69.16% Does the media refer more to COCH or ECOR? In the previous week, electroCore had 3 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for electroCore and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.87 beat electroCore's score of 1.03 indicating that Envoy Medical is being referred to more favorably in the media. Company Overall Sentiment Envoy Medical Very Positive electroCore Positive SummaryEnvoy Medical beats electroCore on 8 of the 15 factors compared between the two stocks. Get Envoy Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCH vs. The Competition Export to ExcelMetricEnvoy MedicalSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.41M$9.54B$5.79B$8.36BDividend YieldN/A1.37%4.89%3.97%P/E RatioN/A18.3024.8919.11Price / Sales98.6047.47373.96113.79Price / CashN/A19.6738.0534.62Price / Book-15.045.817.334.26Net Income-$29.91M$284.66M$3.18B$246.62M7 Day Performance-2.59%-2.63%-3.31%-3.85%1 Month Performance-14.84%-6.58%-7.14%-6.96%1 Year Performance-84.44%-19.93%12.21%3.36% Envoy Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCHEnvoy Medical3.2736 of 5 stars$1.35+1.8%$8.00+490.8%-78.7%$27.41M$278,000.000.0034Positive NewsECORelectroCore2.6976 of 5 stars$17.22-2.5%$25.00+45.2%+117.9%$114.62M$23.33M-9.4150Positive NewsZJYLJin Medical InternationalN/A$0.73-4.4%N/A-89.6%$114.28M$23.50M0.00245Positive NewsLNSRLENSAR1.6706 of 5 stars$9.31+0.2%$8.00-14.1%+186.8%$108.09M$42.16M-6.38110Earnings ReportPDEXPro-Dex3.4775 of 5 stars$33.11+3.5%$52.00+57.1%+114.6%$107.97M$61.00M16.47140Short Interest ↑TELATELA Bio2.8781 of 5 stars$2.65-2.6%$9.25+249.1%-66.9%$104.38M$58.45M-1.57120NSPRInspireMD2.3561 of 5 stars$3.70+16.0%$4.75+28.4%+12.8%$96.51M$6.82M-4.9350Analyst ForecastGap UpHigh Trading VolumeEDAPEdap Tms2.7998 of 5 stars$2.50-3.1%$19.00+660.0%-62.2%$92.76M$63.41M-3.85230Analyst ForecastShort Interest ↑News CoverageFONRFONAR1.915 of 5 stars$14.86+0.7%N/A-35.2%$92.18M$101.57M12.92480SRTSSensus Healthcare3.373 of 5 stars$5.19-3.5%$14.67+182.6%+8.0%$85.06M$41.81M12.9840Short Interest ↓Positive NewsNTRBNutriband2.2164 of 5 stars$7.60+1.9%$13.00+71.1%+174.1%$84.44M$2.09M-10.7010Short Interest ↑ Related Companies and Tools Related Companies electroCore Competitors Jin Medical International Competitors LENSAR Competitors Pro-Dex Competitors TELA Bio Competitors InspireMD Competitors Edap Tms Competitors FONAR Competitors Sensus Healthcare Competitors Nutriband Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:COCH) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.